Status:

COMPLETED

A Comparison of Interventions to Teach Melanoma Patients Skin Self-examination

Lead Sponsor:

Northwestern University

Conditions:

Melanoma

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The almost 724,000 Americans survivors of melanoma are estimated to have 4 first degree relatives per case; thus, 2.8 million Americans are at increased risk of developing melanoma in comparison to th...

Detailed Description

Population based registries document that survival from melanoma, a growing public health problem with approximately 70,000 new melanoma cases and an estimated 8,600 deaths in 2010, is dependent on th...

Eligibility Criteria

Inclusion

  • Personal history of Stage 0 through IIB melanoma
  • At least 6 weeks post surgical treatment of Stage 0 through IIA melanoma
  • Age 18-80 years old
  • Have sufficient vision to read a newspaper in order to visually detect changes on skin
  • Able to read English
  • Have a partner willing to participate in skin checks

Exclusion

  • Subjects overburdened with other co- morbid diseases, medical treatments (e.g. chemotherapy), unable to participate in a conversation at a sixth grade language level due to cognitive impairment (e.g. by a stroke), or prior participation in SSE research.

Key Trial Info

Start Date :

September 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2015

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT01432860

Start Date

September 1 2011

End Date

May 1 2015

Last Update

July 12 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Northwestern University Department of Dermatology

Chicago, Illinois, United States, 60611